AHA: Apixaban Beneficial for Patients With Subclinical A-Fib
Risk for stroke or systemic embolism lower with apixaban versus aspirin for patients with subclinical a-fib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.